Emergency Internal Medicine Treatment and Prognosis of Severe Heart Failure
Objective To carry on internal medicine diagnosis and treatment for severe psychological failure and analyze prognostic effect.Methods The paper divided patients with severe heart failure into two groups randomly(routine group and combination group),treated with routine treatment,metoprolol and irbesartan hydrochlorothiazide treatment(visit time was from January 2021 to January 2022).Curative effect was analyzed and compared.Results Total effective rate of combination group was significantly higher than routine group,(P＜0.05).Systolic blood pressure,diastolic blood pressure,LVEF,and BNP indicators before treatment were similar between two groups,(P＞0.05).After treatment,systolic blood pressure,diastolic blood pressure,and BNP indicators in combination group were lower than routine group,while LVEF indicators were higher than routine group,(P＜0.05).Overall life quality scores of combination group were better than routine group,(P＜0.05).Incidence of complications in combination group was lower than routine group(P＜0.05).Conclusion Metoprolol combined with irbesartan can improve heart function of heart failure patients significantly with good clinical effect,reduce complications,and enhance their life quality.
Severe heart failureEmergency internal medicine treatmentMetoprololIrbesartan hydrochlorothiazideHeart functionLife qualityPrognostic effect
万方数据
维普
